Liraglutide is a human glucagon like peptide-1 (GLP-1) analog, which is used for the treatment of adult type 2 diabetes. Once a day, it can meet the patients' hypoglycemic needs. GLP-1 analogues can effectively control blood sugar, reduce the risk of hypoglycemia, and have both weight loss and cardiovascular benefits.